BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38433277)

  • 1. Pan-cancer and multi-omics analyses revealed the diagnostic and prognostic value of BAZ2A in liver cancer.
    Liu Y; Wang J; Guo J; Zhang Q; Wang S; Hu F; Wu J; Zhao Y; Zhang J; Yu Y; Li Y; Zhang X
    Sci Rep; 2024 Mar; 14(1):5228. PubMed ID: 38433277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carcinoma derived exosomes regulate the proliferation and migration of nasopharyngeal carcinoma cells by mediating the miR-99a-5p BAZ2A axis.
    Zhou XJ; Xu HM; Huang GS; Lin BR
    Braz J Otorhinolaryngol; 2024; 90(1):101343. PubMed ID: 37925811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker.
    Wang Y; Liu T; Zhang K; Huang RH; Jiang L
    Eur J Med Res; 2023 Jul; 28(1):258. PubMed ID: 37501187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Multi-Omics Analysis of Identified Ferroptosis-Marker RPL8 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Liver Cancer.
    Fan S; Zhang S; Kong D; Wang H; Shi Y; Wang Z; Zheng H
    Comb Chem High Throughput Screen; 2023; 26(7):1298-1310. PubMed ID: 36017842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
    Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
    Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells.
    Peña-Hernández R; Aprigliano R; Carina Frommel S; Pietrzak K; Steiger S; Roganowicz M; Lerra L; Bizzarro J; Santoro R
    EMBO Rep; 2021 Nov; 22(11):e53014. PubMed ID: 34403195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the diagnostic value, prognostic value, and biological functions of NPC gene family members in hepatocellular carcinoma based on a multi-omics analysis.
    Chen K; Zhang X; Peng H; Huang F; Sun G; Xu Q; Liao L; Xing Z; Zhong Y; Fang Z; Liao M; Luo S; Chen W; Dong M
    Funct Integr Genomics; 2023 Aug; 23(3):264. PubMed ID: 37541978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.
    Gu L; Frommel SC; Oakes CC; Simon R; Grupp K; Gerig CY; Bär D; Robinson MD; Baer C; Weiss M; Gu Z; Schapira M; Kuner R; Sültmann H; Provenzano M; ; Yaspo ML; Brors B; Korbel J; Schlomm T; Sauter G; Eils R; Plass C; Santoro R
    Nat Genet; 2015 Jan; 47(1):22-30. PubMed ID: 25485837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics data identifies RSPO2 as a prognostic biomarker in human tumors associated with pan-cancer.
    Srivastava A; Srivastava S
    Adv Protein Chem Struct Biol; 2024; 139():469-499. PubMed ID: 38448143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
    Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
    Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer.
    Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z
    Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
    Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
    Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00885 promotes cervical cancer progression through sponging miR-3150b-3p and upregulating BAZ2A.
    Liu Y; Chen J; Zhou L; Yin C
    Biol Direct; 2022 Jan; 17(1):4. PubMed ID: 35012615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma.
    Zhong X; He Z; Fan Y; Yin L; Hong Z; Tong Y; Bi Q; Zhu S
    Aging (Albany NY); 2023 Oct; 15(19):10640-10680. PubMed ID: 37827692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of bromodomain ligands targeting BAZ2A.
    Cazzanelli G; Vedove AD; Parolin E; D'Agostino VG; Unzue A; Nevado C; Caflisch A; Lolli G
    Protein Sci; 2023 Sep; 32(9):e4752. PubMed ID: 37574751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer landscape of CENPO and its underlying mechanism in LUAD.
    Shi T; Hu Z; Tian L; Yang Y
    Respir Res; 2023 Apr; 24(1):113. PubMed ID: 37061713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy.
    Yang Q; Zeng S; Liu W
    PeerJ; 2023; 11():e15019. PubMed ID: 36949759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer.
    Roganowicz M; Bär D; Bersaglieri C; Aprigliano R; Santoro R
    Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37184661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression.
    Zhu J; Chen Q; Zeng L; Gao H; Wu T; He Y; Xu J; Pang J; Peng J; Deng Y; Han Y; Yi W
    Front Immunol; 2023; 14():1236806. PubMed ID: 37901236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.